Harnessing tumor immunogenomics: Tumor neoantigens in ovarian cancer and beyond.

Wu, Mengrui; Zhou, Shengtao

Wu, Mengrui; Zhou, Shengtao.

Wu M; Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, PR China.
Zhou S; Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, PR China. Electronic address: taotaovip2005@163.com.

Biochim Biophys Acta Rev Cancer ; 1878(6): 189017, 2023 11.

Article en En | MEDLINE | ID: mdl-37935309

Asunto(s)

Antígenos de Neoplasias; Neoplasias Ováricas; Humanos; Femenino; Antígenos de Neoplasias/genética; Neoplasias Ováricas/genética; Neoplasias Ováricas/terapia; Inmunoterapia Adoptiva; Mutación; Inmunoterapia

Palabras clave

Immunogenomics; Immunotherapy; Neoantigen; Next-generation sequencing; Ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígenos de Neoplasias Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google